The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓƵ articles
1
The best new science-fiction books of June 2026
2
Pancreatic cancer halted by virus injection in three patients
3
Photons behave very strangely if you try to cut them
4
Glaciers in the 'roof of the world' have suddenly started melting
5
Red-light therapy does have health benefits but not the ones you think
6
Aim high but don't shoot for the moon, mathematicians advise
7
Does gravity create reality? A shocking path to a theory of everything
8
Millions of planets might form around supermassive black holes
9
'The book is in the future, but everything is seeded from our present'
10
First quantum grandfather clock could probe where gravity comes from
